Abbott Launches Jot Dx Insertable Cardiac Monitor to Detect Abnormal Heart Rhythms in US
Shots:
- Abbott launches its latest Jot Dx ICM with new features to help clinicians for a constant flow of heart rhythm data to treat atrial fibrillation
- Jot Dx ICM allows 24/7 heart monitoring and connects directly with Abbott’s myMerlin smartphone app. The technology is designed to provide remote detection and improved diagnostic accuracy of cardiac arrhythmias
- Abbott’s SyncUp provides one-on-one device setup support to connect the patients with Jot Dx ICM and helps to reduce in-clinic burden. Additionally- SyncUP also support Abbott's Gallant ICD
to | Ref: Abbott | Image:Abbott
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
